Arcus Biosciences, Inc. (NYSE:RCUS – Get Rating) traded down 7.8% on Tuesday . The stock traded as low as $17.78 and last traded at $17.99. 387,122 shares traded hands during trading, a decline of 61% from the average session volume of 999,097 shares. The stock had previously closed at $19.52. Wall Street Analyst Weigh In […]
Arcus Biosciences, Inc. (NYSE:RCUS – Get Rating)’s share price was down 7.8% during mid-day trading on Tuesday . The company traded as low as $17.78 and last traded at $17.99. Approximately 387,122 shares changed hands during trading, a decline of 61% from the average daily volume of 999,097 shares. The stock had previously closed at […]
Arcus Biosciences, Inc. (NYSE:RCUS – Get Rating) – Investment analysts at Wedbush dropped their Q2 2023 earnings per share estimates for Arcus Biosciences in a report issued on Wednesday, May 10th. Wedbush analyst R. Driscoll now anticipates that the company will post earnings of ($1.23) per share for the quarter, down from their prior estimate […]
Arcus Biosciences (NYSE:RCUS – Get Rating) posted its quarterly earnings data on Tuesday. The company reported ($1.09) earnings per share for the quarter, missing the consensus estimate of ($1.06) by ($0.03), Briefing.com reports. The firm had revenue of $25.00 million for the quarter, compared to analyst estimates of $22.47 million. Arcus Biosciences had a negative […]
Arcus Biosciences (NYSE:RCUS – Get Rating) issued its quarterly earnings data on Tuesday. The company reported ($1.09) EPS for the quarter, missing analysts’ consensus estimates of ($1.06) by ($0.03), Briefing.com reports. The business had revenue of $25.00 million during the quarter, compared to analyst estimates of $22.47 million. Arcus Biosciences had a negative net margin […]